Unilateral central retinal artery occlusion as the sole presenting sign of Susac syndrome in a young man: case report

Arquivos Brasileiros de Oftalmologia

Samira Luiza Dos Apóstolos-pereira²  Lúcia B. Passos Kara-josé¹  Paulo Euripedes Marchiori²  Mário Luiz Ribeiro Monteiro¹ 

[1],Universidade de São Paulo Department of Neurology São Paulo SP ,Brazil

关键词: Retinal artery occlusion;    Susac syndrome;    Susac syndrome;    Methylprednisolone;    Cyclophosphamide;    Hearing loss;    Encephalopathy;    Case report;    Oclusão da artéria retiniana;    Síndrome de Susac;    Síndrome de Susac;    Metilprednisolona;    Ciclofosfamida;    Perda auditiva;    Encefalopatia;    Relato de caso;   

DOI  :  10.1590/S0004-27492013000300013

来源: SciELO

【 摘 要 】

We report the case of a 24-year-old man presenting with sudden visual loss in the left eye from a central retinal artery occlusion. An extensive clinical investigation revealed no etiology. Three weeks later, however, the patient developed hearing loss followed by encephalopathy and multiple branch retinal artery occlusions in the right eye. Fluorescein angiography confirmed retinal vascular occlusions with no sign of vasculitis. The neurological examination revealed a diffuse encephalopathy while the MRI scan disclosed several small areas of infarcts in the brain. Bilateral sensorineural hearing loss was confirmed on audiometry. The patient was diagnosed with Susac syndrome and treated with methylprednisolone and cyclophosphamide, resulting in slight improvement and stabilization. This case shows that Susac syndrome may be diagnosed late due to the absence at onset of one or more of the symptoms of the classic triad (encephalopathy, multiple branch retinal artery occlusions and hearing loss). This case also serves to emphasize that Susac syndrome should be considered in the differential diagnosis of central retinal artery occlusion, even in apparently healthy young men.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License